FDA Adds A Warning About Liver Deterioration On Weight Loss Pills
May 27th, 2010 - 7:24 pm ICT by Pen Men At WorkMay 27, 2010 (Pen Men at Work): The Food and Drug Administration (FDA) of America has discharged a warning to the American citizens that there exists a probability of massive harm to the liver in rare cases owing to the usage of weight loss pills such as Xenical and alli. The FDA has acknowledged 13 examples of liver injury that were connected with the consumption of these drugs.
The FDA has elucidated that it has included a caution about the danger to the label of the drugs such as alli and Xenical. Alli is vended over-the-counter by GlaxoSmithKline whereas the recommendation version, Xenical, is produced and advertised by Roche.
The FDA has advised the American people to monitor signals of liver deterioration such as yellow eyes and skin, irritation in the body and shortage of hunger.
Roche has stated that Xenical has been supplied to in excess of 36 million patients globally since its launch in 1999 subsequent to the endorsement of the FDA. Roche has clarified that the safety summary of Xenical is anchored in more than 10 years of medical experience.
GlaxoSmithKline has uttered that in excess of 10 million individuals have utilized alli since it was initiated in 2007 after the approval of the FDA. GlaxoSmithKline has mentioned that it will dedicatedly strive to enlighten the medical doctors and patients about the personality of alli and how to use it. GlaxoSmithKline is among the world’ mammoth drug companies and is headquartered in London.
Sales of alli in America rose to $293 million in 2009, which was sizably lesser than the colossal numbers expected by the medicinal market after the drug’s initiation in 2007. Some analysts have declared that the standing of alli has been struck somewhat badly due to its unlikable by-products such as anal seepage.
- Weight Loss Pills 'Alli' & 'Xenical' Get FDA Liver Damage Warning! - May 27, 2010
- FDA wants to puts liver damage warning on Weight loss pills - May 27, 2010
- The Diabetes Drugs, Avandia and Actos, Have The Same Amount of Risks - Aug 29, 2010
- Cheryl Eckard appears on '60 Minutes' show - Jan 03, 2011
- Anti-obesity drug's safety being reviewed amid liver damage fears - Aug 26, 2009
- Diabetes drug 'ups heart disease, death risk' - Feb 22, 2010
- Asthama Drugs Get New FDA Regulations - Feb 19, 2010
- Common Blood Pressure Drugs May Amplify The Risk Of Cancer - Jun 15, 2010
- Drug For Treatment Of Lupus On The Verge Of Being Approved By FDA - Nov 18, 2010
- Swine flu jab under scrutiny over dangerous sleep disorder fears - Aug 28, 2010
- Heart Risk Posed By Diabetes Drugs Avandia Same As Actos, Study Says - Aug 29, 2010
- Brits warned against using anti-obesity pill - Mar 06, 2010
- Man claims Glaxo drug made him a 'gay sex addict' - Feb 01, 2011
- Sudden sleep syndrome may hit kids after swine flu jab - Apr 24, 2011
- Dr Reddy's acquires US-based oral penicillin facility - Nov 24, 2010
Tags: alli, american citizens, food and drug administration, food and drug administration fda, glaxosmithkline, launch, liver injury, london sales, medical doctors, medical experience, men at work, pen men, rare cases, roche, safety summary, seepage, skin irritation, weight loss pills, xenical, yellow eyes